Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β Resistance

Till Ringel; Nina Frey; Femke Ringnalda; Sharan Janjuha; Sarah Cherkaoui; Stefan Butz; Sumana Srivatsa; Martin Pirkl; Giancarlo Russo; Lukas Villiger; Gerhard Rogler; Hans Clevers; Niko Beerenwinkel; Nicola Zamboni; Tuncay Baubec; Gerald Schwank

doi:10.1016/j.stem.2020.02.007

Back

Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β Resistance

Article 2020 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2016

CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids

Gerald Schwank, Hans Clevers

Article2022

Differentiation and CRISPR-Cas9-mediated genetic engineering of human intestinal organoids

Adriana Martínez-Silgado, Fjodor A. Yousef Yengej, Jens Puschhof, Veerle Geurts, Charelle Boot, Maarten H. Geurts, Maarten B Rookmaaker, Marianne C. Verhaar, Joep Beumer, Hans Clevers

Article2024

Decoding endocrine cell differentiation: insights from high‐throughput CRISPR screening in human gut organoids

Lin Lin, Hans Clevers, Lin Lin, Hans Clevers

Article2023

Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis

Delilah Hendriks, Jos F. Brouwers, Karien M. Hamer, Maarten H. Geurts, Léa Luciana, Simone Massalini, Carmen López‐Iglesias, Peter J. Peters, Maria J. Rodríguez Colman, Susana M. Chuva de Sousa Lopes, Benedetta Artegiani, Hans Clevers

Preprint2020

Generation of human knock-in organoids by CRISPR-HOT

Benedetta Artegiani, Delilah Hendriks, Hans Clevers